-
2021-10-12
da73bbc5c1eb9a1044086a1fb6777d31e41f5ee8
16
Bharat Biotech
37
/wiki/bharat%20biotech
COVID-19 pandemic
1
/wiki/covid-19%20pandemic
COVID-19 vaccine
116
/wiki/covid-19%20vaccine
Covaxin
71
/wiki/covaxin
India
2
/wiki/india
drug regulator
14
/wiki/central%20drugs%20standard%20control%20organisation
Bharat Biotech
COVID-19 pandemic
COVID-19 vaccine
Covaxin
India
drug regulator
COVID-19 pandemic
2021-08-27
8c90c9479fbcf66f359a011c77e689c518acd721
/feed/2021/08/27/according-to-government-data-more-than-473-million-people-have-received-at-least-a-dose-of-covid-19-vaccine-which-amou
According to government data, more than 473 million people have received at least a dose of COVID-19 vaccine, which amounts to about half of eligible adults in India. In contrast, only around 15% of eligible adults have been fully vaccinated against COVID-19.
1630098409
2021-08-27
1179602ac31bb3f0d4867b4faead863d963003fe
/feed/2021/08/27/more-than-half-of-india-s-eligible-population-some-473-million-people-have-received-at-least-one-dose-of-a-covid-va
More than half of India's eligible population - some 473 million people - have received at least one dose of a Covid vaccine, official data says. But only about 15% of eligible adults have been fully vaccinated since the beginning of the drive in January.
1630055209
2021-08-27
aa82ea929013e8c660b0dd9a282581ea7248f532
20
COVID-19 pandemic
COVID-19 vaccine
India
3
/feed/2021/08/27/according-to-government-data-more-than-473-million-people-have-received-at-least-one-dose-of-a-covid-19-vaccine-which
According to government data, more than 473 million people have received at least one dose of a COVID-19 vaccine, which amounts to about half of all eligible adults in India. However, only around 15% of eligible adults have been fully vaccinated against COVID-19.
2021-08-20
41420b0f2098b949fc88715a5ad879b2338f00bd
/feed/2021/08/20/the-indian-government-approves-the-emergency-use-of-zycov-d-made-by-cadila-healthcare-which-is-the-world-s-first-three
The Indian government approves the emergency use of ZyCoV-D made by Cadila Healthcare, which is the world's first three-dose and DNA-based COVID-19 vaccine.
1629507978
2021-08-20
70aaaa01a75d77a2c9f647771977f3eefb99044a
14
COVID-19 pandemic
COVID-19 vaccine
India
3
/feed/2021/08/20/the-indian-government-approves-the-emergency-use-of-the-zycov-d-vaccine-made-by-cadila-healthcare-which-is-the-world-s
The Indian government approves the emergency use of the ZyCoV-D vaccine made by Cadila Healthcare, which is the world's first three-dose DNA-based COVID-19 vaccine.
2021-08-9
0334817e75f78c422880dc2c9d57ce66731425ae
/feed/2021/08/9/nepal-begins-to-roll-out-the-second-oxford-astrazeneca-vaccine-dose-for-nearly-14-million-elderly-people-following-a-mo
Nepal begins to roll-out the second Oxford-AstraZeneca vaccine dose for nearly 1.4 million elderly people following a months-long delay due to India halted exports over a massive rise in cases in later country. The vaccines was donated 1.6 million by Japan and 230,000 by Bhutan.
1628564806
2021-08-9
ed056e7fd622ae632545537fdffa8f4a6b0fb8a6
23
COVID-19 pandemic
COVID-19 vaccine
India
3
/feed/2021/08/9/nepal-begins-administering-second-doses-of-the-oxford-astrazeneca-vaccine-dose-for-nearly-14-million-elderly-people-fol
Nepal begins administering second doses of the Oxford-AstraZeneca vaccine dose for nearly 1.4 million elderly people following a months-long delay due to India suspending exports of vaccines due to a substantial increase in the number of cases there. The vaccines were donated by Japan and Bhutan.
2021-07-3
0f359e8f6d8dfaf6fd1e037fe0a9f2714f5dc644
/feed/2021/07/3/phase-iii-trials-of-covaxin-from-india-s-bharat-biotech-showed-652-efficacy-against-the-delta-variant-778-efficacy
Phase-III trials of Covaxin from India's Bharat Biotech showed 65.2% efficacy against the Delta variant, 77.8% efficacy against symptomatic COVID-19, and 93.4% efficacy against severe COVID-19.
1625358351
2021-07-3
b61a2439deca94a662ec61f0c2d826453829718e
15
Bharat Biotech
COVID-19 pandemic
Covaxin
India
4
/feed/2021/07/3/phase-iii-trials-of-the-covaxin-vaccine-from-india-s-bharat-biotech-showed-a-652-efficacy-against-the-delta-variant-a
Phase-III trials of the Covaxin vaccine from India's Bharat Biotech showed a 65.2% efficacy against the Delta variant, a 77.8% efficacy against symptomatic COVID-19, and a 93.4% efficacy against severe COVID-19.
2021-04-2
1ec21ab17691d8dca97c510b99e72ea538da4372
12
COVID-19 pandemic
COVID-19 vaccine
India
3
/feed/2021/04/2/india-reports-a-new-single-day-record-of-367-million-doses-of-the-covid-19-vaccine-administered
India reports a new single-day record of 3.67 million doses of the COVID-19 vaccine administered.
2021-03-30
c07a03207fb5869903c2619069398ad96f7528c3
24
Bharat Biotech
COVID-19 pandemic
Covaxin
3
/feed/2021/03/30/brazil-s-health-regulator-anvisa-said-bharat-biotech-s-covaxin-did-not-meet-its-manufacturing-standards-the-brazilian-g
Brazil's health regulator Anvisa said Bharat Biotech's Covaxin did not meet its manufacturing standards. The Brazilian government previously signed a contract to buy 20 million doses. Bharat said in a statement that they would appeal the decision.
2021-03-27
71bac09c2f1de400347d587109cf571f2b473176
/feed/2021/03/27/bhutan-launches-their-largest-vaccination-campaign-against-covid-19-using-oxford-astrazeneca-vaccine-that-was-received-f
Bhutan launches their largest vaccination campaign against COVID-19 using Oxford-AstraZeneca vaccine that was received from India.
1616893580
2021-03-27
d1658f90569f57a4787fe99e4d50d1adbf9df17f
/feed/2021/03/27/bhutan-launches-the-largest-vaccination-campaign-covid-19-using-oxford-astrazeneca-vaccine-that-was-received-from-india
Bhutan launches the largest vaccination campaign COVID-19 using Oxford-AstraZeneca vaccine that was received from India.
1616857572
2021-03-27
8b1c10715e6542b8e89d133dfca79d7a7b2e48b7
16
COVID-19 pandemic
COVID-19 vaccine
India
3
/feed/2021/03/27/bhutan-launches-their-largest-vaccination-campaign-against-covid-19-using-the-oxford-astrazeneca-vaccine-that-was-receiv
Bhutan launches their largest vaccination campaign against COVID-19 using the Oxford-AstraZeneca vaccine that was received from India.
2021-03-9
258172b9046f84d3efd16ad6824f9a6883884466
/feed/2021/03/9/zimbabwe-grants-the-emergency-use-authorisation-for-four-covid-19-vaccines-including-china-s-coronavac-and-bbibp-corv
Zimbabwe grants the emergency use authorisation for four COVID-19 vaccines, including China's Coronavac and BBIBP-CorV, Russia's Sputnik V, and India's Covaxin.
1615338329
2021-03-9
fd088c708b46cd42025035b38b0024d1036fcde2
31
COVID-19 pandemic
COVID-19 vaccine
Covaxin
India
4
/feed/2021/03/9/zimbabwe-grants-emergency-use-authorization-for-four-covid-19-vaccines-including-china-s-coronavac-and-bbibp-corv-russ
Zimbabwe grants emergency use authorization for four COVID-19 vaccines, including China's CoronaVac and BBIBP-CorV, Russia's Sputnik V, and India's Covaxin.
2021-03-4
f85b94f01d47a4b38f1ac49dc7e66b0829cb6818
/feed/2021/03/4/zimbabwe-becomes-the-first-country-in-africa-to-approve-india-s-first-indigenous-covaxin-vaccine-manufactured-by-bharat
Zimbabwe becomes the first country in Africa to approve India's first indigenous Covaxin vaccine manufactured by Bharat Biotech.
1614906326
2021-03-4
70d7216f7096b2033373f60c8c1c3b9162561b3a
31
Bharat Biotech
COVID-19 pandemic
Covaxin
India
4
/feed/2021/03/4/zimbabwe-becomes-the-first-country-in-africa-to-approve-india-s-covaxin-vaccine-manufactured-by-bharat-biotech
Zimbabwe becomes the first country in Africa to approve India's Covaxin vaccine manufactured by Bharat Biotech.
2021-02-14
788f752f05fb35a2d87b5c8829eeff9688765571
/feed/2021/02/14/mexico-receives-a-shipment-of-870000-doses-of-oxford-astrazeneca-s-vaccine-from-india
Mexico receives a shipment of 870,000 doses of Oxford-AstraZeneca's vaccine from India.
1613358636
2021-02-14
4136ef9a109d3cba24eced2fb9776aa32ee83286
32
COVID-19 pandemic
COVID-19 vaccine
India
3
/feed/2021/02/14/mexico-receives-a-shipment-of-870000-doses-of-the-oxford-astrazeneca-vaccine-from-india
Mexico receives a shipment of 870,000 doses of the Oxford–AstraZeneca vaccine from India.
/feed/2021/10/12/indian-drug-regulator-approves-the-emergency-use-of-the-bharat-biotech-covaxin-vaccine-for-children-aged-between-2-to-18
Hindustan Times
12
2d3ad2bd96ef449fbd44d4eb5dbb7f0494fc731d
10
https://www.hindustantimes.com/india-news/bharat-biotech-s-covaxin-approved-for-emergency-use-in-children-101634029754231.html
2021
Indian drug regulator approves the emergency use of the Bharat Biotech Covaxin vaccine for children aged between 2 to 18.